PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.
about
Chemotherapy options in castration-resistant prostate cancerAssessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer.Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer.Degradable Polyethylenimine-Based Gene Carriers for Cancer Therapy.Measurement of serum prostate cancer markers using a nanopore thin film based optofluidic chip.Docetaxel in very elderly men with metastatic castration-resistant prostate cancer.Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study.
P2860
Q28078477-7E32E6A2-F4B7-43C1-A45E-F5076601E4E1Q30000285-8EA76735-3374-45CC-9C91-B17533239796Q38342823-6A1D71D2-934D-41FC-8B91-73AAE6BA5251Q38850154-B58F7FB9-F8F7-427B-B957-66891D26016FQ39177170-3EF62272-02A0-4070-BB24-4E5FF0A75F27Q40441887-D7DB7A58-2C1C-487F-9FAD-F0BA09C6055FQ41275386-187A3A49-17D3-48D6-AFAB-8F1860C6F716Q41283989-247404FF-2481-40A4-903D-0405CCE4A2A0Q47203358-716AB4BD-A81F-41D2-8977-F08621116CE9
P2860
PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
PSA response rate as a surroga ...... cer: an analysis of 22 trials.
@en
type
label
PSA response rate as a surroga ...... cer: an analysis of 22 trials.
@en
prefLabel
PSA response rate as a surroga ...... cer: an analysis of 22 trials.
@en
P2093
P2860
P1433
P1476
PSA response rate as a surroga ...... cer: an analysis of 22 trials.
@en
P2093
Giulia Rossi
Letizia Laera
Roberto Petrioli
P2860
P2888
P304
10601-10607
P356
10.1007/S13277-014-2559-8
P577
2014-09-07T00:00:00Z
P6179
1052391163